• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Results from implementing updated 2012 World Health Organization Guidance on early-warning indicators of HIV drug resistance in Zimbabwe.实施2012年世界卫生组织关于津巴布韦艾滋病毒耐药性早期预警指标的最新指南的结果。
J Epidemiol Res. 2016;2(2):85-91. doi: 10.5430/jer.v2n2p85.
2
Population-based monitoring of HIV drug resistance early warning indicators in Uganda: A nationally representative survey following revised WHO recommendations.乌干达基于人群的 HIV 耐药性早期预警指标监测:根据世卫组织修订建议进行的全国代表性调查。
PLoS One. 2020 Apr 14;15(4):e0230451. doi: 10.1371/journal.pone.0230451. eCollection 2020.
3
Assessment of the World Health Organization's HIV Drug Resistance Early Warning Indicators in Main and Decentralized Outreach Antiretroviral Therapy Sites in Namibia.纳米比亚主要和分散式外展抗逆转录病毒治疗点的世界卫生组织艾滋病毒耐药性早期预警指标评估
PLoS One. 2016 Dec 1;11(12):e0166649. doi: 10.1371/journal.pone.0166649. eCollection 2016.
4
HIV drug resistance early warning indicators in namibia with updated World Health Organization guidance.纳米比亚的艾滋病毒耐药性早期预警指标及世界卫生组织的最新指南
PLoS One. 2014 Jul 2;9(7):e100539. doi: 10.1371/journal.pone.0100539. eCollection 2014.
5
HIV drug-resistance early-warning indicators and quality care in India: preliminary findings from a pilot study in Pune city.印度的艾滋病毒耐药性早期预警指标与优质护理:浦那市一项试点研究的初步结果
WHO South East Asia J Public Health. 2015 Jul-Dec;4(2):123-129. doi: 10.4103/2224-3151.206681.
6
Monitoring HIV Drug Resistance Early Warning Indicators in Cameroon: A Study Following the Revised World Health Organization Recommendations.喀麦隆艾滋病毒耐药性早期预警指标监测:一项遵循世界卫生组织修订建议的研究
PLoS One. 2015 Jun 17;10(6):e0129210. doi: 10.1371/journal.pone.0129210. eCollection 2015.
7
Feasibility of implementing an integrated tool for improvement of treatment quality and early-warning indicators for HIV drug resistance: a pilot study of centres in India.
WHO South East Asia J Public Health. 2015 Jul-Dec;4(2):184-188. doi: 10.4103/2224-3151.206688.
8
Early warning indicators for HIV drug resistance in Cameroon during the year 2010.2010 年期间喀麦隆的 HIV 耐药性早期预警指标。
PLoS One. 2012;7(5):e36777. doi: 10.1371/journal.pone.0036777. Epub 2012 May 17.
9
Monitoring HIV Drug Resistance: Early Warning Indicators to Assess Performance of Thailand's Antiretroviral Treatment Program.监测艾滋病毒耐药性:评估泰国抗逆转录病毒治疗项目绩效的早期预警指标
J Med Assoc Thai. 2017 Sep;100(9):944-952.
10
Early warning indicators of HIV drug resistance in the southern highlands region of Tanzania: Lessons from a cross-sectional surveillance study.坦桑尼亚南部高地地区艾滋病毒耐药性的早期预警指标:横断面监测研究的经验教训
PLOS Glob Public Health. 2023 Mar 30;3(3):e0000929. doi: 10.1371/journal.pgph.0000929. eCollection 2023.

引用本文的文献

1
A longitudinal review of national HIV policy and progress made in health facility implementation in Eastern Zimbabwe.津巴布韦东部国家艾滋病毒政策的纵向审查及医疗机构实施进展
Health Res Policy Syst. 2018 Sep 21;16(1):92. doi: 10.1186/s12961-018-0358-1.

本文引用的文献

1
Monitoring HIV Drug Resistance Early Warning Indicators in Cameroon: A Study Following the Revised World Health Organization Recommendations.喀麦隆艾滋病毒耐药性早期预警指标监测:一项遵循世界卫生组织修订建议的研究
PLoS One. 2015 Jun 17;10(6):e0129210. doi: 10.1371/journal.pone.0129210. eCollection 2015.
2
HIV drug resistance early warning indicators in namibia with updated World Health Organization guidance.纳米比亚的艾滋病毒耐药性早期预警指标及世界卫生组织的最新指南
PLoS One. 2014 Jul 2;9(7):e100539. doi: 10.1371/journal.pone.0100539. eCollection 2014.
3
Scaling up antiretroviral treatment and improving patient retention in care: lessons from Ethiopia, 2005-2013.扩大抗逆转录病毒治疗规模并提高患者的治疗保留率:来自 2005-2013 年埃塞俄比亚的经验。
Global Health. 2014 May 27;10:43. doi: 10.1186/1744-8603-10-43.
4
Monitoring prevention or emergence of HIV drug resistance: results of a population-based foundational survey of early warning indicators in mainland Tanzania.监测预防或出现艾滋病毒耐药性:坦桑尼亚大陆基于人群的早期预警指标基础调查结果。
BMC Infect Dis. 2014 Apr 11;14:196. doi: 10.1186/1471-2334-14-196.
5
Scaling up antiretroviral therapy in resource-limited settings: adapting guidance to meet the challenges.在资源有限的环境中扩大抗逆转录病毒治疗规模:调整指导以应对挑战。
Curr Opin HIV AIDS. 2013 Jan;8(1):12-8. doi: 10.1097/COH.0b013e32835b8123.
6
Early warning indicators for HIV drug resistance in Cameroon during the year 2010.2010 年期间喀麦隆的 HIV 耐药性早期预警指标。
PLoS One. 2012;7(5):e36777. doi: 10.1371/journal.pone.0036777. Epub 2012 May 17.
7
HIV drug resistance early warning indicators in cohorts of individuals starting antiretroviral therapy between 2004 and 2009: World Health Organization global report from 50 countries.2004 年至 2009 年间开始接受抗逆转录病毒治疗的个体队列中的 HIV 耐药性早期预警指标:来自 50 个国家的世界卫生组织全球报告。
Clin Infect Dis. 2012 May;54 Suppl 4(Suppl 4):S280-9. doi: 10.1093/cid/cis207.
8
Update on World Health Organization HIV drug resistance prevention and assessment strategy: 2004-2011.世界卫生组织 HIV 耐药性预防和评估策略更新:2004-2011 年。
Clin Infect Dis. 2012 May;54 Suppl 4(Suppl 4):S245-9. doi: 10.1093/cid/cis206.
9
Antiretroviral drug supply challenges in the era of scaling up ART in Malawi.在马拉维扩大抗逆转录病毒治疗(ART)规模的时代,抗逆转录病毒药物供应面临的挑战。
J Int AIDS Soc. 2011 Jul 6;14 Suppl 1(Suppl 1):S4. doi: 10.1186/1758-2652-14-S1-S4.
10
Assessments of HIV drug resistance mutations in resource-limited settings.资源有限环境下的HIV耐药性突变评估。
Clin Infect Dis. 2011 Apr 15;52(8):1058-60. doi: 10.1093/cid/cir093.

实施2012年世界卫生组织关于津巴布韦艾滋病毒耐药性早期预警指标的最新指南的结果。

Results from implementing updated 2012 World Health Organization Guidance on early-warning indicators of HIV drug resistance in Zimbabwe.

作者信息

Mungati More, Mhangara Mutsa, Dzangare Janet, Mugurungi Owen, Apollo Tsitsi, Gonese Elizabeth, Kilmarx Peter H, Chakanyuka-Musanhu Christine C, Shambira Gerald, Tshimanga Mufuta

机构信息

AIDS and TB Unit, Ministry of Health and Child Care, Harare, Zimbabwe.

Department of Community Medicine, University of Zimbabwe, Harare, Zimbabwe.

出版信息

J Epidemiol Res. 2016;2(2):85-91. doi: 10.5430/jer.v2n2p85.

DOI:10.5430/jer.v2n2p85
PMID:29862318
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5983043/
Abstract

OBJECTIVE

This study evaluated the performance of sentinel sites in preventing the emergence of HIVDR using Early Warning Indicators (HIVDR EWI) survey.

METHODS

Adult and paediatric patient data on: On time pill pick up, Retention in care, Pharmacy stock-outs, and Dispensing practices was collected. Information from pharmacy registers was verified using facility-held cards. This was a cross-sectional analysis of retrospectively collected data from 72 sites providing both adult and paediatric ART as well as two providing adult ART only. All data were entered into and analysed using a WHO EWI data abstraction electronic tool.

RESULTS

Twenty-one percent of sites providing adult and 4.2% of sites providing paediatric ART managed to meet the target for on time pill pick up. Retention in care indicator was met by 48.7% (95% CI: 36.9-60.6) of sites. ARV stock-outs occurred in 81.1% (95% CI: 70-89.3) adult sites and 63.9% (95% CI: 50-78.6) paediatric sites. ARVs were appropriately dispensed by 86.5% (95% CI: 75.6-93.3) of adult sites and 84.7% (95% CI: 74.3-92.1) of paediatric sites.

CONCLUSIONS

Most sites had low performance in many indicators in this survey and failed to meet the recommended targets. Some policies such as the current buffer stock and storage outside Harare should be revised in order to improve site access to ARVs. The country should prioritize the provision of viral load testing services in all provinces. The electronic patient management system should be rolled out to all ART sites to improve patient tracking and monitoring by sites.

摘要

目的

本研究使用早期预警指标(HIVDR EWI)调查评估了哨点在预防HIV耐药性出现方面的表现。

方法

收集了成人和儿科患者在按时取药、持续接受治疗、药房药品缺货以及配药操作方面的数据。药房登记信息通过机构持有的卡片进行核实。这是一项对从72个提供成人和儿科抗逆转录病毒治疗的地点以及两个仅提供成人抗逆转录病毒治疗的地点回顾性收集的数据进行的横断面分析。所有数据均使用世卫组织EWI数据提取电子工具录入并分析。

结果

提供成人抗逆转录病毒治疗的地点中有21%、提供儿科抗逆转录病毒治疗的地点中有4.2%成功达到了按时取药的目标。48.7%(95%置信区间:36.9 - 60.6)的地点达到了持续接受治疗指标。81.1%(95%置信区间:70 - 89.3)的成人治疗地点和63.9%(95%置信区间:50 - 78.6)的儿科治疗地点出现了抗逆转录病毒药物缺货情况。86.5%(95%置信区间:75.6 - 93.3)的成人治疗地点和84.7%(95%置信区间:74.3 - 92.1)的儿科治疗地点正确配药。

结论

在本次调查中,大多数地点在许多指标上表现不佳,未达到推荐目标。应修订一些政策,如当前的缓冲库存和哈拉雷以外的储存政策,以改善各地点获取抗逆转录病毒药物的情况。该国应优先在所有省份提供病毒载量检测服务。应将电子患者管理系统推广到所有抗逆转录病毒治疗地点,以改善各地点对患者的跟踪和监测。